I like helping people have better outcomes than they would have had if we hadn't stumbled across each other's path. I particularly like helping young people who are creative, teachable, and of high integrity, achieve their goals, particularly when their goals have to do with making people's lives better. I like being involved with disruptive, transformative technology. So, awhile back, I became involved with Axolotl Biosciences Inc. Robyn Quinn of Victoria Tech Journal recently wrote an article that can be seen at https://www.victechjournal.com/p/victoriabased-axolotl-biosciences-3d-printing-tissues-mimic-human-stem-cells and which briefly tells the Axolotl story.
Basically, Axolotl has developed stem cell based bioinks that are used by bioprinters to print (i.e.: fabricate) biological tissues that mimic human tissue characteristics and functionality. Axolotl's initial product is TissuePrint, which, as the current business plan states, is a "highly optimized bioink formulation suitable for 3D printing various cell types and adapted for various bioprinting platforms." The product enables pharmaceutical researchers to test prospective products without placing human beings at risk. TissuePrint is available now as a product. A couple of other products under development are BrainPrint and HeartPrint, bioinks from which neural tissue and cardiac tissue will be printed. Axolotl also offers consulting services.
A few days ago, Axolotl was chosen by Nextstream in a regional tech competition as the winner in the Health and Preparedness category: https://nexstream.is/ns-30-finale-winners-2022.
